Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis.
Buenz
Eric J
EJ
Howe
Charles L
CL
D000367:Age Factors; D017668:Age of Onset; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001323:Autoantibodies / Q000187:drug effects* / Q000276:immunology; D004660:Encephalitis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods*; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D017470:Receptors, Glutamate / Q000276:immunology*
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D017470:Receptors, Glutamate